Hamdallah M, Bhatia AJ: Prevalence of sickle-cell trait in USA adolescents of Central American origin. Lancet. 1995, 346: 707-8. 10.1016/S0140-6736(95)92321-7.
Weissman AM: Preventive health care and screening of Latin American immigrants in the United States. J Am Board Fam Pract. 1994, 7: 310-23.
Diaz-Barrios V: Newborn screening for sickle cell disease and other hemoglobinopathies. New York's experience. Pediatrics. 1989, 83: 872-5.
Frenette PS: Sickle cell vaso-occlusion: multistep and multicellular paradigm. Curr Opin Hematol. 2002, 9: 101-6. 10.1097/00062752-200203000-00003.
Perronne V, Roberts-Harewood M, Bachir D, Roudot-Thoraval F, Delord JM, Thuret I, Schaeffer A, Davies SC, Galacteros F, Godeau B: Patterns of mortality in sickle cell disease in adults in France and England. Hematol J. 2002, 3: 56-60. 10.1038/sj.thj.6200147.
Wierenga KJ, Hambleton IR, Lewis NA: Survival estimates for patients with homozygous sickle-cell disease in Jamaica: a clinic-based population study. Lancet. 2001, 357: 680-3. 10.1016/S0140-6736(00)04132-5.
Barabino GA, McIntire LV, Eskin SG, Sears DA, Udden M: Endothelial cell interactions with sickle cell, sickle trait, mechanically injured, and normal erythrocytes under controlled flow. Blood. 1987, 70: 152-7.
Hebbel RP, Yamada O, Moldow CF, Jacob HS, White JG, Eaton JW: Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: possible mechanism for microvascular occlusion in sickle cell disease. J Clin Invest. 1980, 65: 154-60.
Vargas FF, Blackshear GL: Vascular resistance and transit time of sickle red blood cells. Blood Cells. 1982, 8: 139-45.
Niihara Y, Zerez CR, Akiyama DS, Tanaka KR: Oral L-glutamine therapy for sickle cell anemia: I. Subjective clinical improvement and favorable change in red cell NAD redox potential. Am J Hematol. 1998, 58: 117-21. 10.1002/(SICI)1096-8652(199806)58:2<117::AID-AJH5>3.0.CO;2-V.
Zerez CR, Lachant NA, Lee SJ, Tanaka KR: Decreased erythrocyte nicotinamide adenine dinucleotide redox potential and abnormal pyridine nucleotide content in sickle cell disease. Blood. 1988, 71: 512-5.
Kalra VK, Ying Y, Deemer K, Natarajan R, Nadler JL, Coates TD: Mechanism of cigarette smoke condensate induced adhesion of human monocytes to cultured endothelial cells. J Cell Physiol. 1994, 160: 154-62. 10.1002/jcp.1041600118.
Wali RK, Jaffe S, Kumar D, Kalra VK: Alterations in organization of phospholipids in erythrocytes as factor in adherence to endothelial cells in diabetes mellitus. Diabetes. 1988, 37: 104-11.
Sugihara K, Sugihara T, Mohandas N, Hebbel RP: Thrombospondin mediates adherence of CD36+ sickle reticulocytes to endothelial cells. Blood. 1992, 80: 2634-42.
Hebbel RP, Schwartz RS, Mohandas N: The adhesive sickle erythrocyte: cause and consequence of abnormal interactions with endothelium, monocytes/macrophages and model membranes. Clin Haematol. 1985, 14: 141-61.
Ohnishi ST, Horiuchi KY, Horiuchi K: The mechanism of in vitro formation of irreversibly sickled cells and modes of action of its inhibitors. Biochim Biophys Acta. 1986, 886: 119-29. 10.1016/0167-4889(86)90217-X.
Hebbel RP, Eaton JW, Steinberg MH, White JG: Erythrocyte/endothelial interactions in the pathogenesis of sickle-cell disease: a "real logical" assessment. Blood Cells. 1982, 8: 163-73.
Sultana C, Shen Y, Rattan V, Johnson C, Kalra VK: Interaction of sickle erythrocytes with endothelial cells in the presence of endothelial cell conditioned medium induces oxidant stress leading to transendothelial migration of monocytes. Blood. 1998, 92: 3924-35.
Inwald DP, Kirkham FJ, Peters MJ, Lane R, Wade A, Evans JP, Klein NJ: Platelet and leucocyte activation in childhood sickle cell disease: association with nocturnal hypoxaemia. Br J Haematol. 2000, 111: 474-81. 10.1046/j.1365-2141.2000.02353.x.
Rattan V, Sultana C, Shen Y, Kalra VK: Oxidant stress-induced transendothelial migration of monocytes is linked to phosphorylation of PECAM-1. Am J Physiol. 1997, 273: E453-61.
Zerez CR, Lachant NA, Lent KM, Tanaka KR: Decreased pyrimidine nucleoside monophosphate kinase activity in sickle erythrocytes. Blood. 1992, 80: 512-6.
Klings ES, Farber HW: Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease. Respir Res. 2001, 2: 280-5. 10.1186/rr70.
Anastasi J: Hemoglobin S-mediated membrane oxidant injury: protection from malaria and pathology in sickle cell disease. Med Hypotheses. 1984, 14: 311-20. 10.1016/0306-9877(87)90135-6.
Wetterstroem N, Brewer GJ, Warth JA, Mitchinson A, Near K: Relationship of glutathione levels and Heinz body formation to irreversibly sickled cells in sickle cell anemia. J Lab Clin Med. 1984, 103: 589-96.
Beretta L, Gerli GC, Ferraresi R, Agostoni A, Gualandri V, Orsini GB: Antioxidant system in sickle red cells. Acta Haematol. 1983, 70: 194-7.
Niihara Y, Zerez CR, Akiyama DS, Tanaka KR: Increased red cell glutamine availability in sickle cell anemia: demonstration of increased active transport, affinity, and increased glutamate level in intact red cells. J Lab Clin Med. 1997, 130: 83-90. 10.1016/S0022-2143(97)90062-7.
Setty BN, Kulkarni S, Stuart MJ: Role of erythrocyte phosphatidylserine in sickle red cell-endothelial adhesion. Blood. 2002, 99: 1564-71. 10.1182/blood.V99.5.1564.
Rodgers GP, Schechter AN, Noguchi CT, Klein HG, Nienhuis AW, Bonner RF: Periodic microcirculatory flow in patients with sickle-cell disease. N Engl J Med. 1984, 311: 1534-8.
Wun T, Paglieroni T, Field CL, Welborn J, Cheung A, Walker NJ, Tablin F: Platelet-erythrocyte adhesion in sickle cell disease. J Investig Med. 1999, 47: 121-7.
Lipowsky HH, Sheikh NU, Katz DM: Intravital microscopy of capillary hemodynamics in sickle cell disease. J Clin Invest. 1987, 80: 117-27.
Lipowsky HH, Williams ME: Shear rate dependency of red cell sequestration in skin capillaries in sickle cell disease and its variation with vasoocclusive crisis. Microcirculation. 1997, 4: 289-301.
Salman EK, Haymond MW, Bayne E, Sager BK, Wiisanen A, Pitel P, Darmaun D: Protein and energy metabolism in prepubertal children with sickle cell anemia. Pediatr Res. 1996, 40: 34-40.
Garlick PJ: Assessment of the safety of glutamine and other amino acids. J Nutr. 2001, 131: 2556S-61S.
Ziegler TR, Bazargan N, Leader LM, Martindale RG: Glutamine and the gastrointestinal tract. Curr Opin Clin Nutr Metab Care. 2000, 3: 355-62. 10.1097/00075197-200009000-00005.
Hasebe M, Suzuki H, Mori E, Furukawa J, Kobayashi K, Ueda Y: Glutamate in enteral nutrition: can glutamate replace glutamine in supplementation to enteral nutrition in burned rats?. JPEN J Parenter Enteral Nutr. 1999, 23: S78-82.
Ziegler TR, Benfell K, Smith RJ, Young LS, Brown E, Ferrari-Baliviera E, Lowe DK, Wilmore DW: Safety and metabolic effects of L-glutamine administration in humans. JPEN J Parenter Enteral Nutr. 1990, 14: 137S-146S.